131 related articles for article (PubMed ID: 12441808)
1. Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells.
Chanel C; Staropoli I; Baleux F; Amara A; Valenzuela-Fernandez A; Virelizier JL; Arenzana-Seisdedos F; Altmeyer R
AIDS; 2002 Nov; 16(17):2337-40. PubMed ID: 12441808
[TBL] [Abstract][Full Text] [Related]
2. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G
J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841
[TBL] [Abstract][Full Text] [Related]
3. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
5. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
LaBonte JA; Madani N; Sodroski J
J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
8. CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface.
Martínez-Muñoz L; Barroso R; Dyrhaug SY; Navarro G; Lucas P; Soriano SF; Vega B; Costas C; Muñoz-Fernández MÁ; Santiago C; Rodríguez Frade JM; Franco R; Mellado M
Proc Natl Acad Sci U S A; 2014 May; 111(19):E1960-9. PubMed ID: 24778234
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
Popik W; Alce TM; Au WC
J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
[TBL] [Abstract][Full Text] [Related]
10. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
11. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Martín J; LaBranche CC; González-Scarano F
J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
[TBL] [Abstract][Full Text] [Related]
12. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
Arthos J; Cicala C; Selig SM; White AA; Ravindranath HM; Van Ryk D; Steenbeke TD; Machado E; Khazanie P; Hanback MS; Hanback DB; Rabin RL; Fauci AS
Virology; 2002 Jan; 292(1):98-106. PubMed ID: 11878912
[TBL] [Abstract][Full Text] [Related]
13. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
[TBL] [Abstract][Full Text] [Related]
14. Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions.
Lum JJ; Schnepple DJ; Badley AD
AIDS; 2005 Jul; 19(11):1125-33. PubMed ID: 15990565
[TBL] [Abstract][Full Text] [Related]
15. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
16. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
17. Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope.
Lallos LB; Laal S; Hoxie JA; Zolla-Pazner S; Bandres JC
AIDS Res Hum Retroviruses; 1999 Jul; 15(10):895-7. PubMed ID: 10408726
[TBL] [Abstract][Full Text] [Related]
18. CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.
Borsetti A; Parolin C; Ridolfi B; Sernicola L; Geraci A; Ensoli B; Titti F
J Virol; 2000 Jul; 74(14):6689-94. PubMed ID: 10864687
[TBL] [Abstract][Full Text] [Related]
19. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
20. Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes.
Kuzmina A; Vaknin K; Gdalevsky G; Vyazmensky M; Marks RS; Taube R; Engel S
PLoS One; 2015; 10(12):e0144043. PubMed ID: 26629902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
